Sandbox:Hannan: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
Line 214: | Line 214: | ||
* Work up must exclude Cushing syndrome, pheochromocytoma and adrenal carcinoma | * Work up must exclude Cushing syndrome, pheochromocytoma and adrenal carcinoma | ||
|- | |- | ||
|Carcinoma<ref name="pmid20823463">{{cite journal |vauthors=Nieman LK |title=Approach to the patient with an adrenal incidentaloma |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4106–13 |date=September 2010 |pmid=20823463 |pmc=2936073 |doi=10.1210/jc.2010-0457 |url=}}</ref><ref name="pmid26191527">{{cite journal |vauthors=Libé R |title=Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment |journal=Front Cell Dev Biol |volume=3 |issue= |pages=45 |date=2015 |pmid=26191527 |pmc=4490795 |doi=10.3389/fcell.2015.00045 |url=}}</ref><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid24423978">{{cite journal |vauthors=Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD |title=Adrenocortical carcinoma |journal=Endocr. Rev. |volume=35 |issue=2 |pages=282–326 |date=April 2014 |pmid=24423978 |pmc=3963263 |doi=10.1210/er.2013-1029 |url=}}</ref> | |Carcinoma<ref name="pmid20823463">{{cite journal |vauthors=Nieman LK |title=Approach to the patient with an adrenal incidentaloma |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4106–13 |date=September 2010 |pmid=20823463 |pmc=2936073 |doi=10.1210/jc.2010-0457 |url=}}</ref><ref name="pmid26191527">{{cite journal |vauthors=Libé R |title=Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment |journal=Front Cell Dev Biol |volume=3 |issue= |pages=45 |date=2015 |pmid=26191527 |pmc=4490795 |doi=10.3389/fcell.2015.00045 |url=}}</ref><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid24423978">{{cite journal |vauthors=Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD |title=Adrenocortical carcinoma |journal=Endocr. Rev. |volume=35 |issue=2 |pages=282–326 |date=April 2014 |pmid=24423978 |pmc=3963263 |doi=10.1210/er.2013-1029 |url=}}</ref><ref name="pmid24102952">{{cite journal |vauthors=Wang C, Sun Y, Wu H, Zhao D, Chen J |title=Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers |journal=Histopathology |volume=64 |issue=4 |pages=567–76 |date=March 2014 |pmid=24102952 |pmc=4282325 |doi=10.1111/his.12283 |url=}}</ref> | ||
| | | | ||
| | | |
Revision as of 16:27, 1 February 2019
Cortex | Product | Clinical manifestations | Dianosis | Gold
standard |
Other features | ||||
---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | Blood & Urine | Histopathological | Imaging | Others | ||||
Adenoma | Aldosterone[1][2][3][4] |
|
|
|
|
|
|
|
|
Cortisol[1][5][6][7] |
|
|
|
|
|
|
|
| |
Androgens[4][8][9][10] |
|
|
|
|
|
|
|
| |
Non-functional[1][11][12][13] |
|
|
|
|
|
|
|
| |
Carcinoma[12][14][15][16][17] |
|
|
|
|
|
|
|
| |
Nodular
Hyperplasia |
Adrenal mass | Clinical manifestations | Diagnosis | Gold standard | Other features | ||||
---|---|---|---|---|---|---|---|---|
Symptoms | Signs | Blood & Urine | Histopathological | Imaging | Others | |||
References
- ↑ 1.0 1.1 1.2 Park JJ, Park BK, Kim CK (June 2016). "Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses". Br J Radiol. 89 (1062): 20151018. doi:10.1259/bjr.20151018. PMC 5258164. PMID 26867466.
- ↑ Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P (August 2015). "Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas". Mol. Cell. Endocrinol. 411: 146–54. doi:10.1016/j.mce.2015.04.022. PMC 4474471. PMID 25958045.
- ↑ Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (May 2010). "Laboratory investigation of primary aldosteronism". Clin Biochem Rev. 31 (2): 39–56. PMC 2874431. PMID 20498828.
- ↑ 4.0 4.1 Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C (2013). "Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging". J Clin Imaging Sci. 3: 61. doi:10.4103/2156-7514.124088. PMC 3935261. PMID 24605256.
- ↑ Stratakis CA (2008). "Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome)". Endocr Dev. 13: 117–32. doi:10.1159/000134829. PMC 3132884. PMID 18493137.
- ↑ Zilbermint M, Stratakis CA (June 2015). "Protein kinase A defects and cortisol-producing adrenal tumors". Curr Opin Endocrinol Diabetes Obes. 22 (3): 157–62. doi:10.1097/MED.0000000000000149. PMC 4560837. PMID 25871963.
- ↑ Wei J, Li S, Liu Q, Zhu Y, Wu N, Tang Y, Li Q, Ren K, Zhang Q, Yu Y, An Z, Chen J, Li J (April 2018). "ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures". BMC Endocr Disord. 18 (1): 22. doi:10.1186/s12902-018-0250-6. PMC 5913873. PMID 29685132.
- ↑ Arnold DT, Reed JB, Burt K (January 2003). "Evaluation and management of the incidental adrenal mass". Proc (Bayl Univ Med Cent). 16 (1): 7–12. PMC 1200803. PMID 16278716.
- ↑ Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J (2013). "Pure androgen-secreting adrenal adenoma associated with resistant hypertension". Case Rep Endocrinol. 2013: 356086. doi:10.1155/2013/356086. PMC 3681270. PMID 23819074.
- ↑ Zhou WB, Chen N, Li CJ (January 2019). "A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman". BMC Endocr Disord. 19 (1): 14. doi:10.1186/s12902-019-0342-y. PMC 6343319. PMID 30674304.
- ↑ Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A (October 2016). ""Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study". Ann. Intern. Med. 165 (8): 533–542. doi:10.7326/M16-0547. PMC 5453639. PMID 27479926.
- ↑ 12.0 12.1 Nieman LK (September 2010). "Approach to the patient with an adrenal incidentaloma". J. Clin. Endocrinol. Metab. 95 (9): 4106–13. doi:10.1210/jc.2010-0457. PMC 2936073. PMID 20823463.
- ↑ Li B, Guo Q, Yang H, Guan J (January 2013). "Giant non-functional adrenal adenoma: A case report". Oncol Lett. 5 (1): 378–380. doi:10.3892/ol.2012.978. PMC 3525484. PMID 23255953.
- ↑ Libé R (2015). "Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment". Front Cell Dev Biol. 3: 45. doi:10.3389/fcell.2015.00045. PMC 4490795. PMID 26191527.
- ↑ Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T (September 2018). "CT and MRI of adrenal gland pathologies". Quant Imaging Med Surg. 8 (8): 853–875. doi:10.21037/qims.2018.09.13. PMC 6177362. PMID 30306064.
- ↑ Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (April 2014). "Adrenocortical carcinoma". Endocr. Rev. 35 (2): 282–326. doi:10.1210/er.2013-1029. PMC 3963263. PMID 24423978.
- ↑ Wang C, Sun Y, Wu H, Zhao D, Chen J (March 2014). "Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers". Histopathology. 64 (4): 567–76. doi:10.1111/his.12283. PMC 4282325. PMID 24102952.